Total cancer care moffit cancer center
GO
 

Christine Laronga, MD, FACS

Where You Are:
Christine Laronga, MD, FACS

Senior Member

"Breast cancer has been Dr. Laronga's passion. Her interests cover the entire range from basic science research to patient care: bench to bedside and back."

Office  (888) 860-2778

Education And Training
  • Fellow, University of Texas- MD Anderson Cancer Center, 2000 - Surgical Oncology
  • Resident, University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway, 1997 - General Surgery
  • Research Fellow, University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway, 1994
  • MD, University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School Piscataway, 1991
  • BS, Pennsylvania State University, 1985 - Medicine
  • BA, Pennsylvania State University, 1985 - Italian


Dr. Laronga's research involves creating proteomic profiles for different aspects of breast diseases (race; benign vs. cancer; genetic vs. sporadic breast cancer; etc.) Patient care revolves around diagnosing and treating breast cancer in a compassionate and cutting edge manner.

  • Joh JE, Han G, Kiluk JV, Laronga C, Khakpour N, Lee MC. Indications for axillary ultrasound use in breast cancer patients. Clin Breast Cancer. 2012 Dec;12(6):433-437. Pubmedid: 23062709.
  • Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer. 2012 Dec;118(24):6022-6030. Pubmedid: 22674478. Pmcid: PMC3496800.
  • Joh JE, Esposito NN, Kiluk JV, Laronga C, Khakpour N, Soliman H, Catherine Lee M. Pathologic Tumor Response of Invasive Lobular Carcinoma to Neo-adjuvant Chemotherapy. Breast J. 2012 Nov;18(6):569-574. Pubmedid: 23034096.
  • Laronga C. Going for the gold. Cancer Control. 2012 Oct;19(4):252-253. Pubmedid: 23037492.
  • Parikh RP, Doren EL, Mooney B, Sun WV, Laronga C, Smith PD. Differentiating fat necrosis from recurrent malignancy in fat-grafted breasts: an imaging classification system to guide management. Plast Reconstr Surg. 2012 Oct;130(4):761-772. Pubmedid: 23018689.
  • Deneve JL, Hoefer RA, Harris EE, Laronga C. Accelerated partial breast irradiation: a review and description of an early north american surgical experience with the intrabeam delivery system. Cancer Control. 2012 Oct;19(4):295-308. Pubmedid: 23037497.
  • Laronga C, Lewis JD, Smith PD. The changing face of mastectomy: an oncologic and cosmetic perspective. Cancer Control. 2012 Oct;19(4):286-294. Pubmedid: 23037496.
  • Walsh N, Kiluk JV, Sun W, Khakpour N, Laronga C, Lee MC. Ipsilateral nodal recurrence after axillary dissection for breast cancer. J Surg Res. 2012 Sep;177(1):81-86. Pubmedid: 22498028.
  • Goedendorp MM, Andrykowski MA, Donovan KA, Jim HS, Phillips KM, Small BJ, Laronga C, Jacobsen PB. Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls. Cancer. 2012 Aug;118(15):3833-3841. Pubmedid: 22086766.
  • Laronga C, Harness JK, Dixon M, Borgen PI. The role of the breast cancer surgeon in personalized cancer care: clinical utility of the 21-gene assay. Am J Surg. 2012 Jun;203(6):751-758. Pubmedid: 22516676.
  • Lee MC, Plews R, Rawal B, Kiluk JV, Loftus L, Laronga C. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review. Ann Surg Oncol. 2012 Jun;19(6):1818-1824. Pubmedid: 22203185.
  • Phillips KM, Jim HS, Small BJ, Laronga C, Andrykowski MA, Jacobsen PB. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer. 2012 Apr;118(7):1925-1932. Pubmedid: 22161750. Pmcid: PMC3305821.
  • Acs G, Esposito NN, Kiluk J, Loftus L, Laronga C. A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas. Mod Pathol. 2012 Apr;25(4):556-566. Pubmedid: 22173289.
  • Acs G, Paragh G, Rakosy Z, Laronga C, Zhang PJ. The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma. Mod Pathol. 2012 Feb;25(2):163-177. Pubmedid: 22020194.
  • Bardhan P, Bui MM, Minton S, Loftus L, Carter WB, Laronga C, Ismail-Khan R. HER2-positive male breast cancer with thyroid cancer: an institutional report and review of literature. Ann Clin Lab Sci. 2012;42(2):135-139. Pubmedid: 22585608.
  • Doren EL, Parikh RP, Laronga C, Hiro ME, Sun W, Lee MC, Smith PD, Fulp WJ. Sequelae of fat grafting postmastectomy: an algorithm for management of fat necrosis. Eplasty. 2012;12:e53. Pubmedid: 23308300. Pmcid: PMC3516285.
  • Pimiento JM, Gadgil PV, Santillan AA, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Hartley TL, Yeh IT, Laronga C. Phyllodes tumors: race-related differences. J Am Coll Surg. 2011 Oct;213(4):537-542. Pubmedid: 21856184.
  • Pimiento JM, Lee MC, Esposito NN, Kiluk JV, Khakpour N, Carter WB, Han G, Laronga C. Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion. J Oncol Pract. 2011 Sep;7(5):309-313. Pubmedid: 22211128.
  • Kiluk JV, Lee MC, Park CK, Meade T, Minton S, Harris E, Kim J, Laronga C. Male Breast Cancer: Management and Follow-up Recommendations. Breast J. 2011 Sep;17(5):503-509. Pubmedid: 21883641.
  • Gray JE, Laronga C, Siegel EM, Lee JH, Fulp WJ, Fletcher M, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G, Kim G, Alemany C, Faig D, Sharp P, Markham MJ, Shibata D, Malafa M, Jacobsen PB. Degree of Variability in Performance on Breast Cancer Quality Indicators: Findings From the Florida Initiative for Quality Cancer Care. J Oncol Pract. 2011 Jul;7(4):247-251. Pubmedid: 22043190.
  • Drake RR, Cazares LH, Jones EE, Fuller TW, Semmes OJ, Laronga C. Challenges to developing proteomic-based breast cancer diagnostics. OMICS. 2011 May;15(5):251-259. Pubmedid: 21332380. Pmcid: PMC3128487.
  • Suber J, Malafa M, Smith P, Laronga C. Prosthetic breast reconstruction after implant-sparing mastectomy in patients with submuscular implants. Ann Plast Surg. 2011 May;66(5):546-550. Pubmedid: 21451381.
  • Lee MC, Eatrides J, Chau A, Han G, Kiluk JV, Khakpour N, Cox CE, Carter WB, Laronga C. Consequences of axillary ultrasound in patients with t2 or greater invasive breast cancers. Ann Surg Oncol. 2011 Jan;18(1):72-77. Pubmedid: 20585876.
  • Kiluk JV, Khakpour N, Lee MC, Lowe J, Harris E, Szabunio M, Laronga C. Management of abnormal Rotter's lymph nodes identified on preoperative breast magnetic resonance imaging. Am Surg. 2011 Jan;77(1):E10-E12. Pubmedid: 21396292.
  • Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, Soliman H, Boughey JC, Reynolds C, Lawton TJ, Acs PI, Gordan L, Acs G. The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. Oncologist. 2011;16(11):1520-1526. Pubmedid: 22016474. Pmcid: PMC3233285.
  • Turaga KK, Chau A, Eatrides JM, Kiluk JV, Khakpour N, Laronga C, Lee MC. Selective application of routine preoperative axillary ultrasonography reduces costs for invasive breast cancers. Oncologist. 2011;16(7):942-948. Pubmedid: 21572122. Pmcid: PMC3228129.
  • Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB. Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer. 2010 Dec;116(24):5740-5748. Pubmedid: 20734399.
  • Acs G, Esposito NN, Rakosy Z, Laronga C, Zhang PJ. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma. Am J Surg Pathol. 2010 Nov;34(11):1637-1646. Pubmedid: 20975342.
  • Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH. Breast cancer risk reduction. J Natl Compr Canc Netw. 2010 Oct;8(10):1112-1146. Pubmedid: 20971838.
  • Laronga C. The "molecular" buzz in breast cancer. Cancer Control. 2010 Jul;17(3):140-141. Pubmedid: 20664510.
  • Turaga K, Acs G, Laronga C. Gene expression profiling in breast cancer. Cancer Control. 2010 Jul;17(3):177-182. Pubmedid: 20664515.
  • Rollison DE, Giuliano AR, Risendal BC, Sweeney C, Boulware D, Laronga C, Baumgartner KB, Byers T, Slattery ML. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat. 2010 Jun;121(3):661-669. Pubmedid: 19888649.
  • Sarnaik AA, Meade T, King J, Acs G, Hoover S, Cox CE, Carter WB, Laronga C. Adenoid cystic carcinoma of the breast: a review of a single institution's experience. Breast J. 2010 Mar-Apr;16(2):208-210. Pubmedid: 20030648.
  • Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, Cox CE. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009 Dec;209(6):746-752. Pubmedid: 19959044.
  • Loftus LS, Laronga C. Evaluating patients with chronic pain after breast cancer surgery: the search for relief. JAMA. 2009 Nov;302(18):2034-2035. Pubmedid: 19903928.
  • Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients. Ann Surg Oncol. 2009 Jul;16(7):1973-1981. Pubmedid: 19408048.
  • Acs G, Paragh G, Chuang S, Laronga C, Zhang P. The Presence of Micropapillary Features and Retraction Artifact in Core Needle Biopsy Material Predicts Lymph Node Metastasis in Breast Carcinoma. Am J Surg Pathol. 2009 Feb;33(2):202-210. Pubmedid: 18987549.
  • Wagoner M, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009 Jan;131(1):112-121. Pubmedid: 19095574.
  • Kiluk J, Santillan A, Kaur P, Laronga C, Meade T, Ramos D, Cox C. Feasibility of Sentinel Lymph Node Biopsy Through an Inframammary Incision for a Nipple-Sparing Mastectomy. Ann Surg Oncol. 2008 Dec;15(12):3402-3406. Pubmedid: 18820974.
  • Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML. Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol. 2008 Feb;167(4):447-456. Pubmedid: 18033764. Pmcid: PMC2925515.
  • Shin S, Cazares L, Schneider H, Mitchell S, Laronga C, Semmes OJ, Perry RR, Drake RR. Serum biomarkers to differentiate benign and malignant mammographic lesions. J Am Coll Surg. 2007 May;204(5):1065-1071. Pubmedid: 17481542.
  • Laronga C, Hasson D, Hoover S, Cox J, Cantor A, Cox C, Carter W. Paget's disease in the era of sentinel lymph node biopsy. Am J Surg. 2006 Oct;192(4):481-483. Pubmedid: 16978954.
  • Becker S, Cazares LH, Watson P, Lynch H, Semmes OJ, Drake RR, Laronga C. Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer. Ann Surg Oncol. 2004 Oct;11(10):907-914. Pubmedid: 15383419.
  • Fournier K, Schiller A, Perry RR, Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg. 2004 Jun;239(6):859-863. Pubmedid: 15166965. Pmcid: PMC1356294.
  • Pusztai L, Gregory BW, Baggerly KA, Peng B, Koomen J, Kuerer HM, Esteva FJ, Symmans WF, Wagner P, Hortobagyi GN, Laronga C, Semmes OJ, Wright GL, Drake RR, Vlahou A. Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer. 2004 May;100(9):1814-1822. Pubmedid: 15112261.
  • Vlahou A, Laronga C, Wilson L, Gregory B, Fournier K, McGaughey D, Perry RR, Wright GL, Semmes OJ. A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer. 2003 Aug;4(3):203-209. Pubmedid: 14499014.
  • Laronga C, Becker S, Watson P, Gregory B, Cazares L, Lynch H, Perry RR, Wright GL, Drake RR, Semmes OJ. SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Markers. 2003;19(4-5):229-238. Pubmedid: 15258337.
  • Kiluk J, Laronga C. Commentary on "The Clinical Value of Parasternal Sentinel Lymph Node Biopsy in Breast Cancer".. In: Breast Diseases: a Year Book Quarterly. 2007 ed. St Louis, MO: Mosby Yearbook; 2007;382-383.
  • Laronga C, Kiluk J. Commentary on "Improving surgical outcomes: standardizing the reporting of incidence and severity of acute lymphedema after sentinel lymph node biopsy and axillary node dissection". In: Breast Diseases: a Year Book Quarterly. 2007 ed. St Louis, MO: Mosby Yearbook; 2007;170-171.

Office: (888) 860-2778

BACK TO RESEARCH PAGE
Find a Doctor Schedule an Appointment Login to Patient Portal Outcomes Make a Donation
 
 
TOOLS:   Font Size
 |  Site Map  |  Privacy Policy  |  Terms and Conditions  |  Staff Login